While some of its major pathology-related features have already been studied in depth, including the overexpression of PTGS2 during inflammation and tumorigenesis [32, 6], the complete picture of the regulatory state of this pathway in CRC remains elusive. The gene discussed is PTGS2; the disease is colorectal carcinoma.